PEBRILZO
Live / Applied — First extension granted (statement of use) (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 25 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99354855
- Mark type
- Stylized text
- Filed
- 25 Aug 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- Bentley Olive
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, medical and veterinary preparations for medical purposes for the treatment of bone diseases, metabolic diseases, cancer; Pharmaceutical Oncology Preparations; Biological Oncology Preparations; Biological preparation for medical purpose for the treatment of bone diseases, metastatic diseases, metabolic diseases, cancer
Owner
- Biocon Biologics Limited, Bengaluru, IN
- Biocon Biologics Limited, Bengaluru, IN
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2026 — SOU EXTENSION 1 GRANTED
- 10 Sept 2026 — SOU EXTENSION 1 FILED
- 10 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 05 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Dec 2025 — NON-FINAL ACTION E-MAILED
- 30 Dec 2025 — NON-FINAL ACTION WRITTEN